PBLS Insider Trading Activity and SEC Form 4 Filings
PBLS insider trading summary
Over the past 12 months, insiders at Parabilis Medicines, Inc. (PBLS) reported 62 open-market purchases worth $2.24B by 15 insiders and no sales on SEC Form 4. Net insider buying was $2.24B.
Latest PBLS insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jul 22, 2026 | Peter Kolchinsky | Director | Buy | $1.4M (47,250 @ $29.77) |
| Jul 22, 2026 | Ra Capital Management, L.P. | Insider | Buy | $1.4M (47,250 @ $29.77) |
| Jul 22, 2026 | RA Capital Nexus Fund III, L.P. | Director | Buy | $1.4M (47,250 @ $29.77) |
| Jul 22, 2026 | Rajeev M. Shah | Director | Buy | $1.4M (47,250 @ $29.77) |
| Jul 22, 2026 | RA Capital Healthcare Fund LP | Director | Buy | $1.4M (47,250 @ $29.77) |
| Jul 21, 2026 | RA Capital Healthcare Fund LP | Director | Buy | $190K (6,504 @ $29.17) |
| Jul 21, 2026 | Ra Capital Management, L.P. | Insider | Buy | $1.1M (37,723 @ $30.00) |
| Jul 21, 2026 | RA Capital Nexus Fund III, L.P. | Director | Buy | $190K (6,504 @ $29.17) |
| Jul 21, 2026 | Peter Kolchinsky | Director | Buy | $607K (21,696 @ $27.96) |
| Jul 21, 2026 | Rajeev M. Shah | Director | Buy | $607K (21,696 @ $27.96) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.